Research Centre | Company Search | Charting | Stock Screener | Performance Tables | Financial Diary | Investing Board
Silence Therapeutics (SLN)
Share Price: 206.25p Change Today: 3.75p  Market Cap: 107.45m

SLN Overview

Silence Therapeutics is in the pharmaceuticals & biotechnology sector and is currently trading at 206.25p per share. In the last year Silence Therapeutics's share price has ranged from 179.00p to 375.00p and brokers are currently rating this stock as 'strong buy'.

1 Day Chart

6 Month Chart

SLN Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-09 1.72 (7.51) (246.59)p n/a n/a n/a n/a 0.0%
31-Dec-10 2.37 (8.80) (140.40)p n/a n/a n/a n/a 0.0%
31-Dec-11 0.69 (5.74) (56.17)p n/a n/a n/a n/a 0.0%
31-Dec-12 0.16 (26.28) (6,750.00)p n/a n/a n/a n/a 0.0%
31-Dec-13 0.12 (9.00) (20.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

SLN Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-14 0.01 (11.93) (23.70)p n/a n/a n/a n/a 0.0%
31-Dec-15 n/a (10.77) (20.70)p n/a n/a n/a n/a 0.0%

Copyright © 2014 FactSet Research Systems Inc. All rights reserved.

SLN Company Announcements

Board appointment 15-Dec-2014 07:00 RNS
Trading update and capital markets presentation 01-Dec-2014 07:00 RNS
Technology breakthrough 01-Dec-2014 07:00 RNS

Latest SLN Director Deals

No deals were found in the last 28 days.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 3: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 4: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 5: Forecast figures based on normalised accounts.

 

Price Data

Currency UK Pounds
Share Price 206.25p
Change Today 3.75p
% Change 1.85 %
Volume 988
22-Dec-14 Close 206.25p
Shares Issued 52.10m
Market Cap 107.45m
Year End 31-Dec-13

What The Brokers Say

Strong Buy 1
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 1
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

SLN Dividends

No dividends found

Trades for 22-Dec-2014

Time Volume / Share Price
14:34 964 @ 207.30p
10:32 24 @ 207.30p

SLN Key Personnel

Finance Director Tim Freeborn
CEO Ali Mortazavi
Chair Simon Sturge


www.bolsamania.com www.sharecast.com http://www.proshareclubs.co.uk/ www.digitallook.com